$AQU
Aquaron Acquisition Corp. Stock $aqu

$aqu Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023086702 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$109.0K	$130.0K	$0.00
YoY Change	-48.1%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$109.0K	$130.0K	$0.00
YoY Change	-48.1%
Operating Profit		-$127.4K	-$121.00
YoY Change		105209.92%
Interest Expense	$418.6K	$450.0K
YoY Change	-4.86%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$309.6K	$320.0K	$0.00
YoY Change	40.74%
Income Tax	$27.88K	$91.92K
% Of Pretax Income	9.0%	28.73%
Net Earnings	$281.8K	$253.3K	-$121.00
YoY Change	65.74%	-209409.92%	-31.64%
Net Earnings / Revenue
Basic Earnings Per Share			$0.00
Diluted Earnings Per Share	$0.03	$0.06	$0.00
COMMON SHARES
Basic Shares Outstanding	4.553M shares	4.553M shares	1.250M shares
Diluted Shares Outstanding			1.250M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$340.00	$31.26M	$20.00K
YoY Change	-100.0%	156208.28%	-60.0%
Cash & Equivalents			$15.98K
Short-Term Investments		$31.26M
Other Short-Term Assets	$2.190K	$180.0K	$500.0K
YoY Change	-99.0%	-64.0%	163.16%
Inventory
Prepaid Expenses	$2.188K	$70.85K
Receivables
Other Receivables
Total Short-Term Assets	$2.527K	$31.45M	$510.0K
YoY Change	-100.0%	6066.86%	112.5%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$31.96M
YoY Change
Other Assets	$144.7K
YoY Change
Total Long-Term Assets	$32.10M	$0.00	$4.989K
YoY Change		-100.0%
TOTAL ASSETS
Total Short-Term Assets	$2.527K	$31.45M	$510.0K
Total Long-Term Assets	$32.10M	$0.00	$4.989K
Total Assets	$32.11M	$31.45M	$515.0K
YoY Change	-42.36%	6007.12%	114.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$149.1K	$200.0K
YoY Change	6.46%
Accrued Expenses	$18.50K	$30.00K	$201.7K
YoY Change	85.0%	-85.12%	908.38%
Deferred Revenue
YoY Change
Short-Term Debt	$1.040M	$760.0K	$300.0K
YoY Change		153.33%	50.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.917M	$4.068M	$501.7K
YoY Change	-32.29%	710.85%	128.03%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.526M
YoY Change
Total Long-Term Liabilities	$2.526M	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.917M	$4.068M	$501.7K
Total Long-Term Liabilities	$2.526M	$0.00	$0.00
Total Liabilities	$4.443M	$4.068M	$501.7K
YoY Change	56.94%	710.85%	128.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.296M	-$3.879M	-$11.69K
YoY Change	-2790.22%	33087.76%
Common Stock	$163.00	$163.00	$144.00
YoY Change	0.0%	13.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.295M	-$3.878M	$13.31K
YoY Change
Total Liabilities & Shareholders Equity	$32.11M	$31.45M	$515.0K
YoY Change	-42.36%	6007.12%	114.58%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	$281.8K	$253.3K	-$121.00
YoY Change	65.74%	-209409.92%	-31.64%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$103.2K	-$70.00K	$50.00K
YoY Change	-63.15%	-240.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$277.0K	$25.74M
YoY Change	-99.5%
Cash From Investing Activities	-$277.0K	$25.74M
YoY Change	-99.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	373.3K	-25.73M	-60.00K
YoY Change	-99.33%	42783.33%	-14.29%
NET CHANGE
Cash From Operating Activities	-103.2K	-70.00K	50.00K
Cash From Investing Activities	-277.0K	25.74M
Cash From Financing Activities	373.3K	-25.73M	-60.00K
Net Change In Cash	-6.940K	-60.00K	-10.00K
YoY Change	-113.88%	500.0%	-85.71%
FREE CASH FLOW
Cash From Operating Activities	-$103.2K	-$70.00K	$50.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment		usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	AQUARON ACQUISITION CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity File Number EntityFileNumber	001-41470
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2760193
	dei	Entity Address Address Line1 EntityAddressAddressLine1	515 Madison Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	8th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(646)
	dei	Local Phone Number LocalPhoneNumber	970 2181
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4553150	shares
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	3835	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	57284	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	70846	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	222346	usd
CY2023Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	114673	usd
CY2023Q3	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	31261655	usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	55421229	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	31451009	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	55700859	usd
CY2023Q3	us-gaap	Assets Assets	31451009	usd
CY2022Q4	us-gaap	Assets Assets	55700859	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	201177	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	140075	usd
CY2023Q3	aqu	Franchise Tax Payable FranchiseTaxPayable	26579	usd
CY2022Q4	aqu	Franchise Tax Payable FranchiseTaxPayable	13086	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	295129	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	51753	usd
CY2023Q3	aqu	Exercise Tax Payables ExerciseTaxPayables	259438	usd
CY2023Q3	aqu	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	2525896	usd
CY2022Q4	aqu	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	2525896	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4067845	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2830656	usd
CY2023Q3	us-gaap	Liabilities Liabilities	4067845	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2830656	usd
CY2023Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	0.0001
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	0.0001
CY2023Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2930090	shares
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2930090	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	5417180	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5417180	shares
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	31261655	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	47571463	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	163	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	163	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5138905	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3878654	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	159672	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3878491	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5298740	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31451009	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	55700859	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	117125	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	121	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	718439	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7291	usd
CY2023Q3	us-gaap	Franchisor Costs FranchisorCosts	10300	usd
	us-gaap	Franchisor Costs FranchisorCosts	34400	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-127425	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-121	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-752839	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7291	usd
CY2023Q3	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	548881	usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	1569987	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-100867	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	133387	usd
CY2023Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	320589	usd
CY2022Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-121	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	950535	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-7291	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	91920	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	349036	usd
CY2023Q3	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-24596	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-114673	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	253265	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-121	usd
	us-gaap	Net Income Loss NetIncomeLoss	716172	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7291	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5298740	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	4135212	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	151806	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1315334	usd
CY2023Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	4823546	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-259438	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	311101	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3456549	usd
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	675207	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	253265	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3878491	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20604	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2143	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	18461	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5027	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13434	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-121	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	13313	usd
	us-gaap	Net Income Loss NetIncomeLoss	716172	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7291	usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	1569987	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	133387	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-151500	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	61102	usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	13493	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	323156	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	114673	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-552624	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7291	usd
	us-gaap	Proceeds From Sale Of Investment Projects ProceedsFromSaleOfInvestmentProjects	25943774	usd
	aqu	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount	210000	usd
	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund	129175	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25862949	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	370000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	100000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	210000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-25943774	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	93294	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	300	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25363774	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6406	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-53449	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-885	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57284	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16860	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3835	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15975	usd
	aqu	Deferred Offering Costs In Accrued Offering Expenses DeferredOfferingCostsInAccruedOfferingExpenses	210676	usd
	aqu	Accretion Of Common Stock To Redemption Valuetwo AccretionOfCommonStockToRedemptionValuetwo	9633966	usd
	aqu	Exercise Tax Payable Charged Against Retained Earnings ExerciseTaxPayableChargedAgainstRetainedEarnings	259438	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	79780	usd
	aqu	Other Payable Due To Related Party OtherPayableDueToRelatedParty	99846	usd
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	750000	shares
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10
CY2022Q4	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	4171800	usd
CY2023Q3	us-gaap	Maturity Of Time Deposits MaturityOfTimeDeposits	P185D
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5000001	usd
CY2023Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2487090	shares
	us-gaap	Redemption Premium RedemptionPremium	25943774	usd
	us-gaap	Investment Company Redemption Fee Per Share InvestmentCompanyRedemptionFeePerShare	10.43
CY2023Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	50000	usd
	aqu	Trust Account Per Share TrustAccountPerShare	10.15
CY2023Q2	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	1200000000	usd
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10
CY2023Q3	us-gaap	Investments And Cash InvestmentsAndCash	3835	usd
CY2023Q3	us-gaap	Other Additional Capital OtherAdditionalCapital	886122	usd
	us-gaap	Line Of Credit Facility Periodic Payment LineOfCreditFacilityPeriodicPayment	25000	usd
CY2023Q3	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	300000	usd
CY2023Q1	aqu	Spponsor Loan SpponsorLoan	100000	usd
CY2023Q1	aqu	Spponsor Loan SpponsorLoan	140000	usd
CY2023Q1	aqu	Spponsor Loan SpponsorLoan	130000	usd
CY2023Q2	aqu	Spponsor Loan SpponsorLoan	79780	usd
CY2022Q3	us-gaap	Derivative Average Forward Interest Rate DerivativeAverageForwardInterestRate	0.01	pure
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.01	pure
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	259438	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these unaudited financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2023Q3	us-gaap	Cash Cash	3835	usd
CY2022Q4	us-gaap	Cash Cash	57284	usd
CY2023Q3	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	31261655	usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	55421229	usd
CY2023Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	1703374	usd
	us-gaap	Deferred Policy Acquisition Costs Text Block1 DeferredPolicyAcquisitionCostsTextBlock1	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Deferred Offering Costs</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company complies with the requirements of Financial Accounting Standards Board (the “FASB”) Accounting Standards Codification (the “ASC”) Topic 340-10-S99-1, “Other Assets and Deferred Costs – SEC Materials” and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Offering costs are allocated between public shares and public rights based on the estimated fair values of public shares and public rights at the date of issuance. Deferred offering costs consisted principally of underwriting, legal, accounting and other expenses were charged to stockholders’ equity upon the completion of the IPO on October 6, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2609	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2466	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	114673	usd
CY2023Q3	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	253265	usd
CY2022Q3	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	-121	usd
	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	716172	usd
	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	-7291	usd
CY2023Q3	aqu	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	675207	usd
	aqu	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	9633966	usd
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-421942	usd
CY2022Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-121	usd
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-8917794	usd
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-7291	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of September 30, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
	aqu	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	9633966	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	54171800	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6446444	usd
CY2022	aqu	Allocation Of Offering Costs Related To Redeemable Shares AllocationOfOfferingCostsRelatedToRedeemableShares	-3714253	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	3560360	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	47571463	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	9633966	usd
	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	25943774	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	31261655	usd
CY2022Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5000000	shares
CY2022Q4	us-gaap	Share Price SharePrice	10
CY2022Q4	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	4171800	usd
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2021Q2	aqu	Aggregate Price AggregatePrice	25000	usd
CY2021Q2	aqu	Share Issued And Outstanding Percentage ShareIssuedAndOutstandingPercentage	0.20	pure
	aqu	Subject To Certain Limited Exceptions Percentage SubjectToCertainLimitedExceptionsPercentage	0.50	pure
CY2022Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	200000	usd
CY2022Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	100000	usd
CY2023Q2	us-gaap	Capital Units CapitalUnits	99846	usd
CY2023Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	99846	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	0	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	99846	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.33
	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	210000	usd
CY2022	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	0	usd
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	750000	shares
	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	812577	usd
	aqu	Gross Proceeds GrossProceeds	1896013	usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	100	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	97509	shares
CY2022Q4	us-gaap	Percentage Of Weighted Average Cost Inventory PercentageOfWeightedAverageCostInventory	1.15	pure
CY2023Q3	us-gaap	Marketable Securities MarketableSecurities	31261655	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	55421229	usd
CY2023Q4	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	210000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome		usd
CY2022Q4	aqu	Exercise Tax Payables ExerciseTaxPayables		usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q3	us-gaap	Franchisor Costs FranchisorCosts		usd
	us-gaap	Franchisor Costs FranchisorCosts		usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment		usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities		usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable		usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
	us-gaap	Proceeds From Sale Of Investment Projects ProceedsFromSaleOfInvestmentProjects		usd
	aqu	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount		usd
	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	aqu	Deferred Offering Costs In Accrued Offering Expenses DeferredOfferingCostsInAccruedOfferingExpenses		usd
	aqu	Accretion Of Common Stock To Redemption Valuetwo AccretionOfCommonStockToRedemptionValuetwo		usd
	aqu	Exercise Tax Payable Charged Against Retained Earnings ExerciseTaxPayableChargedAgainstRetainedEarnings		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	aqu	Other Payable Due To Related Party OtherPayableDueToRelatedParty		usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001861063

Files In Submission

Name	View Source	Status
0001213900-23-086702-index-headers.html	Edgar Link	pending
0001213900-23-086702-index.html	Edgar Link	pending
0001213900-23-086702.txt	Edgar Link	pending
0001213900-23-086702-xbrl.zip	Edgar Link	pending
aqu-20230930.xsd	Edgar Link	pending
f10q0923ex31-1_aquaron.htm	Edgar Link	pending
f10q0923ex31-2_aquaron.htm	Edgar Link	pending
f10q0923ex32-1_aquaron.htm	Edgar Link	pending
f10q0923ex32-2_aquaron.htm	Edgar Link	pending
f10q0923_aquaron.htm	Edgar Link	pending
aqu-20230930_cal.xml	Edgar Link	unprocessable
aqu-20230930_pre.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
f10q0923_aquaron_htm.xml	Edgar Link	completed
aqu-20230930_lab.xml	Edgar Link	unprocessable
aqu-20230930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AQU
Aquaron Acquisition Corp. Stock $aqu

2023 Q4 Form 10-Q Financial Statement

#000121390023086702 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQU Aquaron Acquisition Corp. Stock $aqu

2023 Q4 Form 10-Q Financial Statement

#000121390023086702 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQU
Aquaron Acquisition Corp. Stock $aqu